The emergent role of sarcopenia: Preliminary Report of the Observatory of Sarcopenia of the Spanish Society of Geriatrics and Gerontology;La eclosión de la sarcopenia: Informe preliminar del Observatorio de la Sarcopenia de la Sociedad Española de Geriatría y Gerontología

Revista Espanola de Geriatria y Gerontologia

Volumn 46, Issue 2, 2011, Pages 100-110

  Cruz Jentoft, Alfonso J ^a   Triana, Federico Cuesta ^b   Gómez Cabrera, Mari Carmen ^c   López Soto, Alfonso ^d   Masanés, Ferran ^d   Martín, Pilar Matía ^e   Rexach, José Antonio Serra ^f   Hidalgo, Domingo Ruiz ^g   Salvà, Antoni ^g   Viña, José ^d   Formiga, Francesc ^h  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Muscle mass; Muscle strength; Sarcopenia

Indexed keywords

AGING; CLINICAL PRACTICE; GERIATRIC CARE; GERIATRICS; GERONTOLOGY; HEALTH PRACTITIONER; HUMAN; LIFESTYLE; MEDICAL SOCIETY; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; SHORT SURVEY;

EID: 79954883089     PISSN: 0211139X     EISSN: 15781747     Source Type: Journal    
DOI: 10.1016/j.regg.2010.11.004     Document Type: Short Survey

References (136)

1. Cruz-Jentoft A., Landi F., Topinkova E., Michel J.P. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010, 13:1-7.
2. Cruz-Jentoft A., Baeyens J.P., Bauer J.M., Cederholm T., Land F., Martin F.C., et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People. Age Agenig. 2010, 39:412-423.
3. Thomas D.R. Sarcopenia. Clin Geriatr Med. 2010, 26:331-346.
4. Doherty T.J. Invited review: Aging and sarcopenia. J Appl Physiol. 2003, 95:1717-1727.
5. Melton L.J., Khosla S., Crowson C.S., O'Connor M.K., O'Fallon W.M., Riggs B.L. Epidemiology of sarcopenia. J Am Geriatr Soc. 2000, 48:625-630.
6. Castillo E.M., Goodman-Gruen D., Kritz-Silverstein D., Morton D.J., Wingard D.L., Barrett-Connor E. Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med. 2003, 25:226-231.
7. Janssen Y.M.W., Van Houten B., Borm P.A.J., Mossman B.T. Biology of disease: Cell and tissue responses to oxidative damage. Lab Invest. 1993, 69:261-274.
8. Balagopal P., Schimke J.C., Ades P., Adey D., Nair K.S. Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am J Physiol Endocrinol Metab. 2001, 280:E203-208.
9. Ji L.L., Gomez-Cabrera M.C., Vina J. Role of free radicals and antioxidant signaling in skeletal muscle health and pathology. Infect Disord Drug Targets. 2009, 9:428-444.
10. Sies H., Cadenas E. Oxidative stress: damage to intact cells and organs. Philos Trans R Soc Lond B Biol Sci. 1985, 311:617-631.
11. Harman D. Aging: a theory based on free radical and ratiation chemistry. J Gerontol. 1956, 11:298-300.
12. Johnson J.E., Mehler W.R., Miquel J. A fine structural study of degenerative changes in the dorsal column nuclei of aging mice. Lack of protection by vitamin E. J Gerontol. 1975, 30:395-411.
13. Miquel J., Economos A.C., Fleming J., Johnson J.E. Mitochondrial role in cell aging. Exp Gerontol. 1980, 15:575-591.
14. Herbst A., Pak J.W., McKenzie D., Bua E., Bassiouni M., Aiken J.M. Accumulation of mitochondrial DNA deletion mutations in aged muscle fibers: evidence for a causal role in muscle fiber loss. J Gerontol A Biol Sci Med Sci. 2007, 62:235-245.
15. Bua E., Johnson J., Herbst A., Delong B., McKenzie D., Salamat S., et al. Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. Am J Hum Genet. 2006, 79:469-480.
16. Hacker T.A., McKiernan S.H., Douglas P.S., Wanagat J., Aiken J.M. Age-related changes in cardiac structure and function in Fischer 344 x Brown Norway hybrid rats. Am J Physiol Heart Circ Physiol. 2006, 290:H304-311.
17. Melov S., Tarnopolsky M.A., Beckman K., Felkey K., Hubbard A. Resistance exercise reverses aging in human skeletal muscle. PLoS ONE. 2007, 2:e465.
18. Marzetti E., Wohlgemuth S.E., Lees H.A., Chung H.Y., Giovannini S., Leeuwenburgh C. Age-related activation of mitochondrial caspase-independent apoptotic signaling in rat gastrocnemius muscle. Mech Ageing Dev. 2008, 129:542-549.
19. Navarro A., Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol. 2007, 292:C670-686.
20. Johnston A.P., De Lisio M., Parise G. Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl Physiol Nutr Metab. 2008, 33:191-199.
21. Figueiredo P.A., Powers S.K., Ferreira R.M., Appell H.J., Duarte J.A. Aging impairs skeletal muscle mitochondrial bioenergetic function. J Gerontol A Biol Sci Med Sci. 2009, 64:21-33.
22. Lopez-Lluch G., Irusta P.M., Navas P., de Cabo R. Mitochondrial biogenesis and healthy aging. Exp Gerontol. 2008, 43:813-819.
23. Reznick R.M., Zong H., Li J., Morino K., Moore I.K., Yu H.J., et al. Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab. 2007, 5:151-156.
24. Vina J., Gomez-Cabrera M.C., Borras C., Froio T., Sanchis-Gomar F., Martinez-Bello V.E., et al. Mitochondrial biogenesis in exercise and in ageing. Adv Drug Deliv Rev. 2009, 61:1369-1374.
25. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev. 2003, 24:78-90.
26. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998, 92:829-839.
27. Reid M.B., Li Y.P. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res. 2001, 2:269-272.
28. Lee C.E., McArdle A., Griffiths R.D. The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clin Nutr. 2007, 26:524-534.
29. Leger B., Derave W., De Bock K., Hespel P., Russell A.P. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res. 2008, 11:163-175.
30. Greiwe J.S., Cheng B., Rubin D.C., Yarasheski K.E., Semenkovich C.F. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. Faseb J. 2001, 15:475-482.
31. Vasilaki A., McArdle F., Iwanejko L.M., McArdle A. Adaptive responses of mouse skeletal muscle to contractile activity: The effect of age. Mech Ageing Dev. 2006, 127:830-839.
32. Cai D., Frantz J.D., Tawa N.E., Melendez P.A., Oh B.C., Lidov H.G., et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell. 2004, 119:285-298.
33. Lin J., Wu H., Tarr P.T., Zhang C.Y., Wu Z., Boss O., et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 2002, 418:797-801.
34. Hakimi P., Yang J., Casadesus G., Massillon D., Tolentino-Silva F., Nye C.K., et al. Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse. J Biol Chem. 2007, 282:32844-32855.
35. Musaro A., McCullagh K., Paul A., Houghton L., Dobrowolny G., Molinaro M., et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet. 2001, 27:195-200.
36. Potthoff M.J., Olson E.N., Bassel-Duby R. Skeletal muscle remodeling. Curr Opin Rheumatol. 2007, 19:542-549.
37. Rosenberg I.H. Summary comments. Am J Clin Nutr. 1989, 50:1231-1233.
38. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J Nutr. 1997, 127:990S-991S.
39. Evans W.J. What is sarcopenia?. J Gerontol A Biol Sci Med Sci. 1995, 50(Suppl):5-8.
40. Hughes V.A., Frontera W.R., Roubenoff R., Evans W.J., Singh M.A. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002, 76:473-481.
41. Rolland Y., Czerwinski S., Abellan Van Kan G., Morley J.E., Cesari M., et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008, 12:433-450.
42. Gallagher D. Appendicular skeletal muscle mass: effects of age, gender and ethnicity. J Appl Physiol. 1997, 83:229-239.
43. Baumgartner R.N., Koehler K.M., Gallagher D., Romero L., Heymsfield S.B., Ross R.R., et al. Epidemiolgy of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998, 147:755-763.
44. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impaiment and physical disability. J Am Geriatr Soc. 2002, 50:889-896.
45. Newman A.B., Kupelian V., Visser M., Simonsick E., Goodpaster B., Nevitt M., et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003, 51:1602-1609.
46. Janssen I., Baumgartner R.N., Ross R., Rosenberg I.H., Roubenoff R. Skeletal muscle cutpoints associated with elevated phiysical disability risk in older men and women. Am J Epidemiol. 2004, 159:413-421.
47. Masanés F., Culla A., Navarro-González M., Navarro-López M., Sacanella E., López-Soto A. Prevalencia de sarcopenia en ancianos sanos de la comunidad. Rev Clin Esp. 2008, 208 Suppl:S65.
48. Baumgartner R.N. Body composition in healthy aging. Ann N Y Acad Sci. 2000, 904:437-448.
49. Visser M., Kritchevsky S.B., Goodpaster B.H., Newman A.B., Nevitt M., Stamm E., et al. Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study. J Am Geriatr Soc. 2002, 50:897-904.
50. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J Nutr. 1997, 127(5 Suppl):S990-S991.
51. Jansen I. Influence of sarcopenia on the development of physical disability: the cardiovascular Health Study. J Am Geriatr Soc. 2006, 54:56-62.
52. Baumgartner R.N., Wayne S.J., Waters D.L., Janssen I., Gallagher D., Morley J.E. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. 2004, 12:1995-2004.
53. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med. 2001, 56:M146-156. Cardiovascular Health Study Collaborative Research Group.
54. Janssen I., Shepard D.S., Katzmarzyk P.T., Roubenoff R. The health care costs of sarcopenia in United States. J Am Geriatr Soc. 2004, 52:80-85.
55. Woodrow G. Body composition analysis techniques in the aged adult: indications and limitations. Curr Opin Clin Nutr Metab Care. 2009, 12:8-14.
56. Proctor D.N., O'Brien P.C., Atkinson E.J., Nair K.S. Comparasion of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol. 1999, 277:E489-495.
57. Kim J., Wang Z., Heymsfield S.B., Baumgartner R.N., Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr. 2002, 76:378-383.
58. Chien M., Huang T., Wu Y. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc. 2008, 56:1710-1715.
59. Janssen I., Heymsfield S.B., Baumgartner R.N., Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000, 89:465-471.
60. Salinari S., Bertuzzi A., Mingrone G., Capristo G., Scarfone A., Greco A.V., et al. Bioimpedance analysis: a useful technique for assessing appendicular lean soft tissue mass and distribution. J Appl Physiol. 2003, 94:1552-1556.
61. Abellan van Kan G., Rolland Y., Andrieu S., Bauer J., Beauchet O., Bonnefoy M., et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009, 13:881-889.
62. Morley J.E., Baumgartner R.N., Roubenoff R., Mayer J., Sreekumaran N.K. Sarcopenia. J Lab Clin Med. 2001, 137:231-243.
63. Muscaritoli M., Anker S.D., Argilés J., Aversa Z., Bauer J.M., Biolo G., et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) «cachexia-anorexia in chronic wasting diseases» and «nutrition in geriatrics». Clin Nutr. 2010, 29:154-159.
64. Thomas D.R. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr. 2007, 26:389-399.
65. Gaffney-Stomberg E., Insogna K.L., Rodriguez N.R., Kerstetter J.E. Increasing dietary protein requirements in elderly people for optimal muscle and bone health. J Am Geriatr Soc. 2009, 57:1073-1079.
66. Kim J.S., Wilson J.M., Lee S.R. Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants. J Nutr Biochem. 2010, 21:1-13.
67. Evans W.J. Protein nutrition, exercise and aging. J Am Coll Nutr. 2004, 23:S601-609.
68. Flakoll P., Sharp R., Baier S., Levenhagen D., Carr C., Nissen S. Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition. 2004, 20:445-451.
69. Fujita S., Rasmussen B.B., Cadenas J.G., Drummond M.J., Glynn E.L., Sattler F.R., et al. Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes. 2007, 56:1615-1622.
70. Volpi E., Mittendorfer B., Rasmussen B.B., Wolfe R.R. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab. 2000, 85:4481-4490.
71. Fulle S., Protasi F., Di Tano G., Pietrangelo T., Beltramin A., Boncompagni S., et al. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol. 2004, 39:17-24.
72. Semba R.D., Lauretani F., Ferrucci L. Carotenoids as protection against sarcopenia in older adults. Arch Biochem Biophys. 2007, 458:141-145.
73. Semba R.D., Blaum C., Guralnik J.M., Moncrief D.T., Ricks M.O., Fried L.P. Carotenoid and vitamin E status are associated with indicators of sarcopenia among older women living in the community. Aging Clin Exp Res. 2003, 15:482-487.
74. Howard C., Ferrucci L., Sun K., Fried L.P., Walston J., Varadhan R., et al. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol. 2007, 103:17-20.
75. Paddon-Jones D., Rasmussen B.B. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009, 12:86-90.
76. Borst S.E. Interventions for sarcopenia and muscle weakness in older people. Age Ageing. 2004, 33:548-555.
77. Esmarck B., Andersen J.L., Olsen S., Richter E.A., Mizuno M., Kjaer M. Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans. J Physiol. 2001, 535:301-311.
78. Little J.P., Phillips S.M. Resistance exercise and nutrition to counteract muscle wasting. Appl Physiol Nutr Metab. 2009, 34:817-828.
79. Verdijk L.B., Jonkers R.A., Gleeson B.G., Beelen M., Meijer K., Savelberg H.H., et al. Protein supplementation before and after exercise does not further augment skeletal muscle hypertrophy after resistance training in elderly men. Am J Clin Nutr. 2009, 89:608-616.
80. Fujita S., Volpi E. Amino acids and muscle loss with aging. J Nutr. 2006, 136:S277-280.
81. Katsanos C.S., Kobayashi H., Sheffield-Moore M., Aarsland A., Wolfe R.R. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab. 2006, 291:E381-E387.
82. Dillon E.L., Sheffield-Moore M., Paddon-Jones D., Gilkison C., Sanford A.P., Casperson S.L., et al. Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin Endocrinol Metab. 2009, 94:1630-1637.
83. Bischoff Ferrari H.A. Validated treatments and therapeutic perspectivas regarding nutritherapy. J Nutr Health Aging. 2009, 13:737-741.
84. Whigham L.D., Watras A.C., Schoeller D.A. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr. 2007, 85:1203-1211.
85. Nissen S.L., Sharp R.L. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol. 2003, 94:651-659.
86. Houston D.K., Nicklas B.J., Ding J., Harris T.B., Tylavsky F.A., Newman A.B., et al. Health ABC Study. Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr. 2008, 87:150-155.
87. Layman D.K. Dietary Guidelines should reflect new understandings about adult protein needs. Nutr Metab (Lond). 2009, 6:12.
88. Lindle R.S., Metter E.J., Lynch N.A., Fleg J.L., Fozard J.L., Tobin J., et al. Age and gender comparisons of muscle strength in 654 women and men aged 20-93 years. J Appl Physiol. 1997, 83:1581-1587.
89. Aniansson A., Sperling L., Rundgren A., Lehnberg E. Muscle function in 75 year old men and women: a longitudinal study. Scand J Rehab Suppl. 1983, 9:92-102.
90. Fiatarone-Singh M.A. Exercise comes from age: rationale and recommendations for a geriatric exercise prescription. J Gerontol Med Sci. 2002, 57A:M262-M282.
91. McDermott A.Y., Mernitz H. Exercise and older patients: prescribing guidelines. Am Fam Physician. 2006, 74:437-444.
92. Phillips S.M. Resistance exercise: good for more than just grandma and grandpa's muscles. Appl Physiol Nutr Metab. 2007, 32:1198-1205.
93. Fiatarone M.A., Marks E.C., Ryan N.D., Meredith C.N., Lipsitz L.A., Evans W.J. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA. 1990, 263:3029-3034.
94. Hagerman F.C., Walsh S.J., Staron R.S., Hikida R.S., Gilders R.M., Murray T.F., et al. Effects of high-intensity resistance training on untrained older men. I. Strength, cardiovascular, and metabolic responses. J Gerontol A: Biol Sci Med Sci. 2000, 55:B336-B346.
95. Chodzko-Zajko W.J., Proctor D.N., Fiatarone Singh M.A., Minson C.T., Nigg C.R., Salem G.J., et al. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc. 2009, 41:1510-1530. American College of Sports Medicine.
96. Nelson M.E., Rejeski W.J., Blair S.N., Duncan P.W., Judge J.O., King A.C., et al. Physical activity and public health in older adults. Recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007, 116:1094-1105.
97. Latham N.K., Bennett D.A., Stretton C.M., Anderson C.S. Systematic review of progressive resistance strength training in older adults. J Gerontol A Biol Sci Med Sci. 2004, 59:48-61.
98. Latham N, Anderson C, Bennett D, Stretton C. Progressive resistance strength training for physical disability in older people. Cochrane Database of Systematic Reviews 2003, Issue 2. Art. N.°1: CD002759. DOI: 10.1002/14651858.CD002759.
99. Lynch G.S., Ryall J.G. Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev. 2008, 88:729-767.
100. Bischoff-Ferrari H.A., Dawson-Hugues B., Willet W.C., Staehelin H.B., Bazemore M.G., Zee R.Y., et al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004, 291:1999-2006.
101. Lathman N.K., Anderson C.S., Reid I.R. Effects of vitamin D supplementation on strenght, physical performance, and falls in older persons: a systematic review. J Am Geriatr Soc. 2003, 51:1219-1226.
102. Annweiler C., Schott A.M., Berrut G., Fantino B., Beauchet O. Viatmin D-related changes in physical performance: a systematic review. J Nutr Health Aging. 2009, 13:893-898.
103. Stechschulte S.A., Kirsner R.S., Federman D.G. Vitamin D: Bone and beyond, rationale and recommendations for supplementation. Am J Med. 2009, 122:793-802.
104. Bhasin S. Testosterone supplementation for aging-associated sarcopenia. J Gerontol A Biol Sci Med Sci. 2003, 58A:M1002-M1008.
105. Van den Beld A.W., De Jong F.H., Grobbee D.E., Pols H.A., Lamberts S.W. Measures of bioaivailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab. 2000, 85:3276-3282.
106. Sih R., Morley J.E., Kaiser F.E., Perry H.M., Patrick P., Ross C. Testosterone replacement in older hypogonadal men a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997, 82:1661-1667.
107. Page S.T., Amory J.K., Bowman F.D., Anawalt B.D., Matsumoto A.M., Bremner W.J., et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab. 2005, 90:1502-1510.
108. Kenneth J., Ottenbacher M.E., Ottenbacher A.J., Acha A.A., Ostir G.V. Androgen treatment and muscle strenght in elderly men: a meta-analysis. J Am Geriatr Soc. 2006, 54:1666-1673.
109. Storer T.W., Magliano L., Woodhouse L., Lee M.L., Dzekov C., Dzeckov J., et al. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab. 2003, 88:1478-1485.
110. Kenny A.M., Kleppinger A., Annis K., Rathier M., Browner B., Judge J.O., et al. Effects of transdermal testosterone levels, low bone mass, and physical frailty. J Am Geriatr Soc. 2010, 58:1134-1143.
111. Valenti G., Denti L., Maggio M., Ceda G., Volpato S., Bandinelli S., et al. Effect of DHEAS on skeletal muscle over the life span: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004, 59:466-472.
112. Igwebuike A., Irving B.A., Bigelow M.L., Short K.R., McConnell J.P., Nair K.S. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J Clin Endocrinol Metab. 2008, 93:534-538.
113. Nair K.S., Rizza R.A., O'Brien P., Dhatariya K., Short K.R., et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Eng J Med. 2006, 355:1647-1659.
114. Percheron G., Hogrel J.Y., Denot-Ledunois S., Fayet G., Forette F., Baulieu E.E., et al. Effect of 1-year oral administration of dehydroepiandrosterone to 60-to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med. 2003, 163:720-727.
115. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., Yen S.S. The effect of six months treatment with a 100mg daily dose of dehydroepiandosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age advance men and women. Clin Endocrinol (Oxf). 1998, 49:421-432.
116. Rimbom E.L., Piehl-Aulin K., Ljunghall S., Ljunggren O., Naessén T. Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women. Maturitas. 2002, 42:225-231.
117. Kenny A.M., Kleppinger A., Wang Y., Prestwood K.M. Effects of ultra-low-dose estrogen therapy on muscle and physical function in older women. J Am Geriatr Soc. 2005, 53:1973-1977.
118. Chen Z., Bassford T., Green S.B., Cauley J.A., Jackson R.D., LaCroix A.Z., et al. Postmenopausal hormone therapy and body composition-a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am J Clin Nutr. 2005, 82:651-666.
119. Meeuwsen I.B., Samson M.M., Duursma S.A., Verhaar H.J. Muscle strength and tibolone: a randomized double-blind, placebo-controlled trial. BJOG. 2002, 109:77-84.
120. Papadakis M.A., Grady D., Black D., Tierney M.J., Gooding G.A., Schambelan, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med. 1996, 124:708-716.
121. Hennessey J.V., Chromiak J.A., Dellaventura S., Reinert S.E., Puhl J., Kiel D.P., et al. Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people. J Am Geriatr Soc. 2001, 49:852-857.
122. Chu L.W., Lam K.S., Hu W.J., Hui S.L., Chiu A., Chiu K.C., et al. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients. J Clin Endocrinol Metab. 2001, 86:1913-1920.
123. Götherström G., Elbornsson M., Stibrant-Sunnerhagen K., Bengtsson B.A., Johannsson G., Svensson J. Muscle strength in elderly adults with growth hormone (GH) deficiency after ten years of GH replacement. Eur J Endocrinol. 2010, 163:207-215.
124. Blackman M.R., Sorkin J.D., Münzer T., Bellantoni M.F., Busby-Whitehead J., Stevens T.E., et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. 2002, 288:2282-2292.
125. Giannoulis M.G., Sonksen P.H., Umpleby M., Breen L., Pentecost C., Whyte M., et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab. 2006, 91:477-484.
126. Sattler F.R., Castaneda-Sceppa C., Binder E.F., Schroeder E.T., Wang Y., Bhasin S., et al. Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab. 2009, 94:1991-2001.
127. Nass R., Pezzoli S.S., Oliveri M.C., Patrie J.T., Harrell F.E., Clasey J.L., et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008, 149:601-611.
128. White H.K., Petrie C.D., Lanschulz W., MacLean D., Taylor A., Lyles K., et al. Effects of an oral growth hormone secretagogue in older adults. J Clin Endocrinol Metab. 2009, 94:1198-2006. Capromorelin Study Group.
129. Sumukadas D., Struthers A.D., McMurdo M.E. Sarcopenia-a potential target for Angiotensin-converting enzyme inhibition?. Gerontology. 2006, 52:237-242.
130. Onder G., Pennix B.W., Balkrishnan R., Fried L.P., Chaves P.H., Williamson J., et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet. 2002, 359:926-930.
131. Sumukadas D., Withmam M.D., Struthers A.D., McMurdo M.E. Effect of perindropril on physical function in elderly people with functional impairment: a randomized controlled trial. CMAJ. 2007, 177:867-874.
132. Cesari M., Pedone C., Incalzi R.A., Pahor M. ACE-inhibition and physical function: results from the Trial of angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. J Am Med Dir Assoc. 2010, 11:26-32.
133. Bunout D., Barrera G., De la Maza M.P., Leiva L., Backhouse C., Hirsch S. Effects of enalapril or nifedipine on muscle strength or functional capacity in elderly subjects: A double blind trial. J Renin Angiotensin Aldosterone Syst. 2009, 10:77-84.
134. Tsuchida K. Targeting myostatin for therapies against muscle-wasting disorders. Curr Opin Drug Discov Devel. 2008, 11:487-494.
135. Solomon A.M., Bouloux M.G. Modifying muscle mass: the endocrine perspective. J Endocrinol. 2006, 191:349-360.
136. Lynch G.S. Emerging drugs for sarcopenia: age-related muscle wasting. Expert Opin Emerg Drugs. 2004, 9:345-361.